Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial.

Falardeau J, Fryman A, Wanchu R, Marracci GH, Mass M, Wooliscroft L, Bourdette DN, Murchison CF, Hills WL, Yadav V.

Mult Scler J Exp Transl Clin. 2019 May 13;5(2):2055217319850193. doi: 10.1177/2055217319850193. eCollection 2019 Apr-Jun.

2.

Effects of lipoic acid on primary murine microglial cells.

Chaudhary P, Marracci G, Pocius E, Galipeau D, Morris B, Bourdette D.

J Neuroimmunol. 2019 Sep 15;334:576972. doi: 10.1016/j.jneuroim.2019.576972. Epub 2019 May 27.

PMID:
31176014
3.

Myelin repair stimulated by CNS-selective thyroid hormone action.

Hartley MD, Banerji T, Tagge IJ, Kirkemo LL, Chaudhary P, Calkins E, Galipeau D, Shokat MD, DeBell MJ, Van Leuven S, Miller H, Marracci G, Pocius E, Banerji T, Ferrara SJ, Meinig JM, Emery B, Bourdette D, Scanlan TS.

JCI Insight. 2019 Apr 18;4(8). pii: 126329. doi: 10.1172/jci.insight.126329. eCollection 2019 Apr 18.

4.

Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.

Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, Riddehough A, Li DK, McDougall J, Lovera J, Murchison C, Bourdette D.

Mult Scler Relat Disord. 2016 Sep;9:80-90. doi: 10.1016/j.msard.2016.07.001. Epub 2016 Jul 6.

5.

Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.

Shinto L, Marracci G, Mohr DC, Bumgarner L, Murchison C, Senders A, Bourdette D.

PLoS One. 2016 Jan 22;11(1):e0147195. doi: 10.1371/journal.pone.0147195. eCollection 2016.

6.

Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.

Chaudhary P, Marracci G, Galipeau D, Pocius E, Morris B, Bourdette D.

J Neuroimmunol. 2015 Dec 15;289:68-74. doi: 10.1016/j.jneuroim.2015.10.011. Epub 2015 Nov 11.

7.

Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis.

Su KG, Savino C, Marracci G, Chaudhary P, Yu X, Morris B, Galipeau D, Giorgio M, Forte M, Bourdette D.

Eur J Neurosci. 2012 Feb;35(4):562-71. doi: 10.1111/j.1460-9568.2011.07972.x. Epub 2012 Jan 25.

8.

The effects of omega-3 Fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis.

Shinto L, Marracci G, Bumgarner L, Yadav V.

Autoimmune Dis. 2011;2011:134592. doi: 10.4061/2011/134592. Epub 2011 Jul 20.

9.

Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.

Axthelm MK, Bourdette DN, Marracci GH, Su W, Mullaney ET, Manoharan M, Kohama SG, Pollaro J, Witkowski E, Wang P, Rooney WD, Sherman LS, Wong SW.

Ann Neurol. 2011 Sep;70(3):362-73. doi: 10.1002/ana.22449. Epub 2011 Jun 14.

10.

Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis.

Chaudhary P, Marracci G, Yu X, Galipeau D, Morris B, Bourdette D.

J Neuroimmunol. 2011 Apr;233(1-2):90-6. doi: 10.1016/j.jneuroim.2010.12.002. Epub 2011 Jan 7.

11.

Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.

Yadav V, Marracci GH, Munar MY, Cherala G, Stuber LE, Alvarez L, Shinto L, Koop DR, Bourdette DN.

Mult Scler. 2010 Apr;16(4):387-97. doi: 10.1177/1352458509359722. Epub 2010 Feb 11.

12.

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

Shinto L, Marracci G, Baldauf-Wagner S, Strehlow A, Yadav V, Stuber L, Bourdette D.

Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):131-6. doi: 10.1016/j.plefa.2008.12.001. Epub 2009 Jan 25.

13.

Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.

Salinthone S, Schillace RV, Marracci GH, Bourdette DN, Carr DW.

J Neuroimmunol. 2008 Aug 13;199(1-2):46-55. doi: 10.1016/j.jneuroim.2008.05.003. Epub 2008 Jun 17.

14.

Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.

Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7558-63. Epub 2007 Apr 26. Erratum in: Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17554. Rahder, Micha [added]; Stem, Katie [added].

15.

Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.

Schillace RV, Pisenti N, Pattamanuch N, Galligan S, Marracci GH, Bourdette DN, Carr DW.

Biochem Biophys Res Commun. 2007 Mar 2;354(1):259-64. Epub 2007 Jan 3.

16.
17.

Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck).

Marracci GH, Marquardt WE, Strehlow A, McKeon GP, Gross J, Buck DC, Kozell LB, Bourdette DN.

Biochem Biophys Res Commun. 2006 Jun 9;344(3):963-71. Epub 2006 Apr 5.

PMID:
16631599
18.

Lipoic acid in multiple sclerosis: a pilot study.

Yadav V, Marracci G, Lovera J, Woodward W, Bogardus K, Marquardt W, Shinto L, Morris C, Bourdette D.

Mult Scler. 2005 Apr;11(2):159-65.

PMID:
15794388
19.

Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis.

Marracci GH, McKeon GP, Marquardt WE, Winter RW, Riscoe MK, Bourdette DN.

J Neurosci Res. 2004 Nov 1;78(3):362-70.

PMID:
15389837
20.

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis.

Marracci GH, Jones RE, McKeon GP, Bourdette DN.

J Neuroimmunol. 2002 Oct;131(1-2):104-14.

PMID:
12458042
21.
22.

Molecular cloning and cell-specific growth characterization of polymorphic variants of type D serogroup 2 simian retroviruses.

Marracci GH, Avery NA, Shiigi SM, Couch G, Palmer H, Pilcher KY, Nichols H, Hallick LM, Axthelm MK, Machida CA.

Virology. 1999 Aug 15;261(1):43-58.

23.

Simian AIDS type D serogroup 2 retrovirus: isolation of an infectious molecular clone and sequence analyses of its envelope glycoprotein gene and 3' long terminal repeat.

Marracci GH, Kelley RD, Pilcher KY, Crabtree L, Shiigi SM, Avery N, Leo G, Webb MC, Hallick LM, Axthelm MK, et al.

J Virol. 1995 Apr;69(4):2621-8.

Supplemental Content

Loading ...
Support Center